stoxline Quote Chart Rank Option Currency Glossary
  
Allurion Technologies Inc. (ALUR)
1.59  -0.04 (-2.45%)    05-28 16:00
Open: 1.7
High: 1.7
Volume: 50,601
  
Pre. Close: 1.63
Low: 1.5
Market Cap: 76(M)
Technical analysis
2024-05-28 4:50:46 PM
Short term     
Mid term     
Targets 6-month :  2.41 1-year :  2.83
Resists First :  2.07 Second :  2.43
Pivot price 1.84
Supports First :  1.49 Second :  1.23
MAs MA(5) :  1.61 MA(20) :  1.93
MA(100) :  2.52 MA(250) :  4.64
MACD MACD :  -0.2 Signal :  -0.2
%K %D K(14,3) :  10.5 D(3) :  8.3
RSI RSI(14): 37.2
52-week High :  10.93 Low :  1.49
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ ALUR ] has closed above bottom band by 18.6%. Bollinger Bands are 6.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 1.7 - 1.71 1.71 - 1.72
Low: 1.48 - 1.49 1.49 - 1.5
Close: 1.57 - 1.59 1.59 - 1.6
Company Description

Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon) and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. The company is headquartered in Natick, Massachusetts.

Headline News

Wed, 22 May 2024
Allurion Technologies (ALUR) vs. The Competition Head-To-Head Contrast - Defense World

Mon, 20 May 2024
Allurion Technologies Inc. Forecasted to Earn FY2024 Earnings of ($0.44) Per Share (NYSE:ALUR) - MarketBeat

Mon, 20 May 2024
Chardan Capital Research Analysts Raise Earnings Estimates for Allurion Technologies Inc. (NYSE:ALUR) - Defense World

Wed, 15 May 2024
Allurion Announces Three Scientific Presentations at the European Congress on Obesity, Including Study on Lean ... - Business Wire

Wed, 17 Apr 2024
Allurion Technologies Secures Growth with Strategic Refinancing - TipRanks.com - TipRanks

Thu, 04 Apr 2024
Allurion Expands Virtual Care Suite to the United States - Business Wire

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Outperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Outperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
NYSE
Sector:
Healthcare
Industry:
Medical - Devices
Shares Out 48 (M)
Shares Float 30 (M)
Held by Insiders 23.8 (%)
Held by Institutions 24.3 (%)
Shares Short 527 (K)
Shares Short P.Month 292 (K)
Stock Financials
EPS -2.31
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) -1.49
Profit Margin -150.8 %
Operating Margin -387.9 %
Return on Assets (ttm) -80.4 %
Return on Equity (ttm) 0 %
Qtrly Rev. Growth -57.1 %
Gross Profit (p.s.) 0
Sales Per Share 1.11
EBITDA (p.s.) -1.64
Qtrly Earnings Growth 0 %
Operating Cash Flow -64 (M)
Levered Free Cash Flow -33 (M)
Stock Valuations
PE Ratio -0.69
PEG Ratio 0
Price to Book value -1.08
Price to Sales 1.42
Price to Cash Flow -1.2
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android